Dialyzer Membranes: High-Flux vs Low-Flux & Biocompatibility

What a dialysis membrane does

The dialyzer contains thousands of hollow fibers made of semipermeable membrane. Blood flows inside the fibers; dialysate flows outside, countercurrent. Small molecules (urea, creatinine, potassium) diffuse across; fluid is pulled by ultrafiltration; larger molecules are cleared only if the pores are big enough — that's the flux difference.

The two performance numbers that matter: clearance (how much of a molecule is removed per minute — driven by surface area, blood flow, and KoA) and ultrafiltration coefficient (Kuf — how easily water passes).

High-flux vs low-flux

Low-flux membranes: small pores — they clear small molecules but not beta-2 microglobulin (B2M, ~11.8 kDa), the protein that accumulates and causes dialysis-related amyloidosis (joint pain, carpal tunnel) after years of dialysis.

High-flux membranes: larger pores that remove B2M and some larger middle molecules. They've become the default for new dialyzers — with evidence of benefit in subgroups and no downside in the pivotal trial.

The HEMO study (NEJM 2002, 1,846 patients): high-flux vs low-flux showed no overall survival difference — but post-hoc analyses found fewer cardiac deaths and better outcomes in patients who'd been on dialysis longer (3.7+ years). Modern practice: high-flux standard, with the real focus on delivered dose (spKt/V ≥1.2) and convection when indicated (HDF).

Materials and biocompatibility

Membrane material determines how the blood reacts. Old cuprophane (cellulose) membranes activated complement and white cells — causing the 'first-use syndrome' (chest pain, hypotension). Modern synthetic membranes — polysulfone, polyethersulfone (PES), polyamide, PMMA, AN69, PAES — are much more biocompatible.

Biocompatibility matters most in the acute setting (sepsis, ICU) and for patients with inflammation; for stable chronic patients the differences are subtle. Some membranes add adsorption capacity (AN69 adsorbs cytokines — useful in some acute indications).

Dialyzer reuse: once common (US), now declining — single-use high-flux dialyzers are standard in most regions. Reuse required rigorous reprocessing and is associated with infection risk when done poorly.

Choosing and sizing a dialyzer

Selection inputs: body size (BSA — larger patients need more surface area), prescribed blood flow, session time, and target clearance. The KoA (mass transfer-area coefficient) predicts clearance for a given flow — higher KoA = more efficient membrane.

Typical: a 1.5-1.8 m² surface-area high-flux dialyzer for standard adults; small patients or children get smaller dialyzers; large patients may need 2.0 m²+ or longer sessions.

The bottom line for patients: the dialyzer matters less than the delivered dose. A well-run 4-hour session with adequate blood flow, good access, and Kt/V ≥1.2 beats any membrane choice — which is why adequacy testing (Kt/V) is the real quality measure.